Dr Christopher Richards, Nanoco’s Chairman, will make the following statement in respect of the Group’s trading performance in the first four months of the financial year ending 31 July 2019.
“Since we updated the market in mid-October with our preliminary results, we have continued to make good progress in delivering the various scopes of work for our US Customer for materials used in the electronics industry. Our Runcorn facility expansion remains on track to be completed by the end of the current calendar year and we continue to deliver excellent performance in enhancing the quality and performance of our next generation materials. The Runcorn plant will enter its next development phase in January 2019 when it will undergo commissioning and stress testing prior to commercial volume manufacture early in the first half of the next financial year.
“In CFQD and Display, our focus has been on enhancing the performance of our materials. Here too we are delivering improved results to our licensees and application partners.
“We continue to work with a range of customers and partners on a number of near term potentially transformative technological and commercial activities. These opportunities span a wide range of applications and end markets, emphasizing the platform nature of our unique, patent protected nano-material technology. These opportunities will support the business as it transitions through this exciting phase in our evolution. We remain confident in delivering the Board’s expectations for our full year results.”
Nanoco Group plc (LON: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, will hold its Annual General Meeting later this morning at its headquarters in Manchester.
